medigraphic.com
Anales de Otorrinolaringología Mexicana

2014, Number 3

<< Back Next >>

Otorrinolaringología 2014; 59 (3)

Clinical Practice Guide of Dysphonia Based on Evidence

Saavedra-Mendoza AGM, Akaki-Caballero M

Language: Spanish
References: 39
Page: 195-208
PDF size: 383.75 Kb.


ABSTRACT

Dysphonia is defined as the symptom manifested by alterations in production or quality of voice, pitch or volume which impairs communication and that has implications on the quality of life. It is present in multiple disorders or diseases that may be intrinsic to the larynx or manifestations of systemic diseases; therefore we are faced with a symptom with a broad spectrum of etiologies with an important impact on labor and social life and which deserves an appropriate systematic approach to provide an optimal treatment. In Mexico there’s no clinical practice guideline, based on the best sustained medical evidence, in diagnostic and/or therapeutic maneuvers, avoiding unnecessary, costly steps or involving loss of time for the integral management of the patient who suffers from it, by what raises this dysphonia clinical practice guideline based in recommendations according to the quality of evidence from the medical literature taking into account the GRADE system to issue these recommendations. Key steps within the medical history are analyzed for diagnostic and therapeutic systematization of the patient with dysphonia. In general, the guideline deployment shows a significant reduction in time since the patient’s initial evaluation to adequate and specific treatment to the basic problem that causes dysphonia, also avoid both unnecessary diagnostic and therapeutic steps and reduce the use and abuse of unjustified empirical medication.


REFERENCES

  1. Roy N, Merril RM, Gray SD, et al. Voice disorders in the general population: prevalence, risk factors and occupational impact. Laryngoscope 2005;115:1988-1995.

  2. Roy N, Merrill RM, Thibeault S, et al. Prevalence of voice disorders in teachers and the general population. J Speech Lang Hear Res 2004;47:281-293.

  3. Duff MC, Proctor A, Yairi E. Prevalence of voice disorders in African American and European American preschoolers. J Voice 2004;18:348-353.

  4. Schwartz SR, Cohen SM, Dailey SH, Rosenfeld RM, et al. Clinical practice guideline: Hoarseness (Dysphonia). Otolaryngol Head and Neck Surg 2009;141:1-31.

  5. Núñez BF, Corte SP. Adaptación y validación del índice de incapacidad vocal (VHI-30) y su versión abreviada (VHI-10) al español. Acta Otorrinolaringol Esp 2007;58:386-392.

  6. Ahmed TF, Khandwala F, Abelson TI, et al. Chronic laryngitis associated with gastroesophageal reflux: prospective assessment of differences in practice patterns between gastroenterologists and ENT physicians. Am J Gastroenterol 2006;101:470-478.

  7. Santos PM, Afrassiabi A, Weymuller EA Jr. Risk factors associated with prolonged intubation and laryngeal injury. Otolaryngol Head Neck Surg 1994;111:453-459.

  8. Gilman M, Merati AL, Klein AM, et al. Performer’s attitudes toward seeking health care for voice issues: understanding the barriers. J Voice 2007;23:225-228.

  9. Abaza MM, Levy S, Hawkshaw MJ, et al. Effects of medications on the voice. Otolaryngol Clin North Am 2007;40:1081-1090.

  10. Brouha XD, Tromp DM, de Leeuw JR, et al. Laryngeal cancer patients: analysis of patient delay at different tumor stages. Head Neck 2005;27:289-295.

  11. Belafsky PC, Rees CJ. Laryngopharyngeal reflux: the value of otolaryngology examination. Curr Gastroenterol Rep 2008;10:278-282.

  12. Patel R, Dailey S, Bless D. Comparison of high-speed digital imaging with stroboscopy for laryngeal ima- ging of glottal disorders. Ann Otol Rhinol Laryngol 2008;117:413-424.

  13. Sataloff RT, Spiegel JR, Hawkshaw MJ. Strobovideolaryngoscopy: results and clinical value. Ann Otol Rhinol Laryngol 1991;100:725-727.

  14. Brenner DJ, Hall EJ. Computed tomography—an increasing source of radiation exposure. N Engl J Med 2007;357:2277- 2284.

  15. Wang CL, Cohan RH, Ellis JH, et al. Frequency, outcome, and appropriateness of treatment of nonionic iodinated contrast media reactions. Am J Roentgenol 2008;191:409- 415.

  16. Dillman JR, Ellis JH, Cohan RH, et al. Frequency and severity of acute allergic-like reactions to gadolinium-containing i.v. contrast media in children and adults. AJR Am J Roentgenol 2007;189:1533-1538.

  17. Chung SM. Safety issues in magnetic resonance imaging. J Neuroophthalmol 2002;22:35-39.

  18. Pretorius PM, Milford CA. Investigating the hoarse voice. BMJ 2008;337:1165-1168.

  19. Dworkin JP. Laryngitis: types, causes, and treatments. Otolaryngol Clin North Am 2008;41:419-436.

  20. Reveiz L, Cardona Zorrilla AF, Ospina EG. Antibiotics for acute laryngitis in adults. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD004783. DOI: 10.1002/14651858.CD004783.pub3.

  21. Fardet L, Kassar A, Cabane J, et al. Corticosteroid-induced adverse events in adults: frequency, screening and prevention. Drug Saf 2007;30:861-881.

  22. Lavy JA, Wood G, Rubin JS, et al. Dysphonia associated with inhaled steroids. J Voice 2000;14:581-588.

  23. Mirza N, Kasper Schwartz S, Antin-Ozerkis D. Laryngeal findings in users of combination corticosteroid and bronchodilator therapy. Laryngoscope 2004;114:1566-1569.

  24. Sulica L. Laryngeal thrush. Ann Otol Rhinol Laryngol 2005;114:369-375.

  25. Gallivan GJ, Gallivan KH, Gallivan HK. Inhaled corticosteroids: hazardous effects on voice—an update. J Voice 2007;21:101-111.

  26. Dean CM, Sataloff RT, Hawkshaw MJ, et al. Laryngeal sarcoidosis. J Voice 2002;16:283-288.

  27. Branski RC, Bhattacharyya N, Shapiro J. The reliability of the assessment of endoscopic laryngeal findings associated with laryngopharyngeal reflux disease. Laryngoscope 2002;112:1019-1024.

  28. Qua CS, Wong CH, Gopala K, et al. Gastro-oesophageal reflux disease in chronic laryngitis: prevalence and response to acid-suppressive therapy. Aliment Pharmacol Ther 2007;25:287-295.

  29. Reichel O, Dressel H, Wiederänders K, et al. Double-blind, placebo controlled trial with esomeprazole for symptoms and signs associated with laryngopharyngeal reflux. Otolaryngol Head Neck Surg 2008;139:414-420.

  30. Park W, Hicks DM, Khandwala F, et al. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope 2005;115:1230-1238.

  31. Milstein CF, Charbel S, Hicks DM, et al. Prevalence of laryngeal irritation signs associated with reflux in asymptomatic volunteers: impact of endoscopic technique (rigid vs. flexible laryngoscope). Laryngoscope 2005;115:2256- 2261.

  32. Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index (RSI). J Voice 2002;16:274-277.

  33. Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding score (RFS). Laryngoscope 2001;111:1313-1317.

  34. Thomas LB, Stemple JC. Voice therapy: Does science support the art? Communicative Disorders Review 2007;1:49- 77.

  35. Anderson T, Sataloff RT. The power of voice therapy. Ear Nose Throat J 2002;81:433-434.

  36. American Speech-Language-Hearing Association. The use of voice therapy in the treatment of dysphonia. 2005. http://www.asha.org/docs/html/TR2005-00158.html.

  37. Friedrich G, Remacle M, Birchall M, et al. Defining phonosurgery: a proposal for classification and nomenclature by the Phonosurgery Committee of the European Laryngological Society (ELS). Eur Arch Otorhinolaryngol 2007;264:1191-1200.

  38. Johns MM. Update on the etiology, diagnosis, and treatment of vocal fold nodules, polyps, and cysts. Curr Opin Otolaryngol Head Neck Surg 2003;11:456-461.

  39. Ruotsalainen JH, Sellman J, Lehto L, et al. Interventions for preventing voice disorders in adults. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD006372. DOI: 10.1002/14651858.CD006372.pub2.




2020     |     www.medigraphic.com